European Heart Journal Advance Access published online on October 11, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi574
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' Collaboration
1 Division of Cardiology, North York General Hospital, Toronto, Canada
* To whom correspondence should be addressed.
Editorial
2 Division of Cardiology, McMaster University, Hamilton, Canada
3 Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Canada
Subodh Verma, E-mail: subodh.verma{at}sympatico.ca or Dr.Marty@bellnet.ca
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. H. Strauss and A. S. Hall Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox Circulation, August 22, 2006; 114(8): 838 - 854. [Full Text] [PDF] |
||||
![]() |
M. H. Strauss, E. Lonn, and S. Verma Angiotensin-II receptor blockers and coronary artery disease: 'presumed innocents': reply Eur. Heart J., June 2, 2006; 27(12): 1507 - 1508. [Full Text] [PDF] |
||||
![]() |
M. Volpe, G. Tocci, and C. Savoia Angiotensin II receptor blockers and coronary artery disease: 'presumed innocents' Eur. Heart J., June 2, 2006; 27(12): 1506 - 1507. [Full Text] [PDF] |
||||

